An observational study in Epilepsy, Tumor and Other, sponsored by MedtronicNeuro. Completed at 7 sites in United States. Per ClinicalTrials.gov, last updated 2022-05-04.
Sponsored by MedtronicNeuro (part of Medtronic) · Observational
The purpose of the VIVID-1 data collection study is to establish a database of clinical images and associated technical files from commercial cases using the Visualase Thermal Therapy System (VTTS). All data collected will be de-identified. No safety or effectiveness assessments will be completed.
1,842 studies on the registry are indexed under Epilepsy; 423 are open to participants now.
This study's enrollment of 183 is above the median of 101 across 536 observational studies indexed under Epilepsy.
Browse Epilepsy studies →MedtronicNeuro is the lead sponsor of 74 studies on the registry; 2 are open to participants now.
Of its 21 completed or terminated interventional studies of FDA-regulated products, 17 (81%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients who have previously received treatment with VTTS when used as intended.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
1. Patient correlating with the de-identified data set to be collected received standard of care treatment using the Visualase System prior to the date of site activation.
Exclusion Criteria:
VTTS as standard of care.
Device: Visualase Thermal Therapy System
Patients who have previously received treatment with VTTS when used as intended.
Also known as: VTTS
Image assessment
Identify pathologies and tissue types prescribed Visualse Thermal Therapy
Time frame: During the Procedure
Plan to share: No
No publications or documents are linked to this record.
Ran from Mar 2018 to primary completion in Apr 2022, 49 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.